DC
ACAD icon

Deere & Company’s Acadia Pharmaceuticals ACAD Stock Holding History

Deere & Company’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-9,308
Closed -$230K – 960
2014
Q3 		$230K Sell
9,308
-9,200
-50% -$215K 0.01% 820
2014
Q2 		$418K Buy
18,508
+3,985
+27% +$83.2K 0.02% 684
2014
Q1 		$353K Buy
14,523
+4,205
+41% +$106K 0.02% 701
2013
Q4 		$258K Sell
10,318
-22,090
-68% -$521K 0.01% 810
2013
Q3 		$890K Buy
32,408
+2,288
+8% +$47.8K 0.05% 388
2013
Q2 		$547K Buy
+30,120
New +$415K 0.03% 605

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deere & Company's ACAD Position: Q4 2014 in Review

Deere & Company sold out of Acadia Pharmaceuticals (ACAD) in Q4 2014, closing a stake of 9,308 shares — an estimated $230K sold.

Deere & Company first reported a position in ACAD in Q2 2013 and held it in 6 quarters. The position peaked at $890K in Q3 2013. 182 funds tracked by Wall St. Rank hold ACAD as of Q4 2014.

  • Deere & Company reported no remaining Acadia Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Deere & Company sold 9,308 Acadia Pharmaceuticals shares in Q4 2014, an estimated $230K.
  • Deere & Company first reported a position in Acadia Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Deere & Company's Acadia Pharmaceuticals position peaked at $890K in Q3 2013.
  • 182 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2014.

Based on Deere & Company's 13F filing for Q4 2014, filed 12 Feb 2015.